Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENO1 | P06733 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | NOS3 | P29474 | 2/20 | 0.39 |
| ▸ | NOS1 | P29475 | 2/20 | 0.39 |
| ▸ | NOS2 | P35228 | 2/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.37 |
| ▸ | MMP9 | P14780 | 1/20 | 0.37 |
| ▸ | PER2 | O15055 | 1/20 | 0.35 |
| ▸ | CRY2 | Q49AN0 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | ACE | P12821 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13074068 | 0.98 | ENO1 (0.41) | ENO1CYP3A4TSHRTDP1MAPT | |
| SCHEMBL13074065 | 0.94 | ENO1 (0.47) | ENO1CYP3A4TSHRTDP1MAPT | |
| SCHEMBL1524639 | 0.86 | — | — | |
| SCHEMBL8468401 | 0.85 | ENO1 (0.40) | ENO1CYP3A4TSHRTDP1MAPT | |
| SCHEMBL28636739 | 0.80 | ENO1 (0.39) | ENO1CYP3A4TSHRTDP1MAPT | |
| SCHEMBL10877680 | 0.78 | NOS3 (0.40) | NOS3NOS1NOS2PER2CRY2 | |
| SCHEMBL9321533 | 0.77 | NOS3 (0.39) | NOS3NOS1NOS2PER2CRY2 | |
| SCHEMBL14025940 | 0.77 | PER2 (0.40) | NOS3NOS1NOS2PER2CRY2 | |
| SCHEMBL3475826 | 0.77 | NOS3 (0.39) | NOS3NOS1NOS2PER2CRY2 | |
| SCHEMBL9692949 | 0.77 | NOS3 (0.43) | TSHRNOS3NOS1NOS2PER2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109337097-B | Solvent and method for preparing cellulose solution by using same | 绍兴美标纺织品检验有限公司 | 2021-10-01 | — | — | CN | claimed |
| US-20150024436-A1 | SAMPLE PREPARATION, PROCESSING AND ANALYSIS SYSTEMS | INTEGENX INC, (US) | 2015-01-22 | — | — | US | claimed |
| US-12497478-B2 | High molecular weight block copolymers comprising repeating units derived from monomers comprising lactam and acryloyl moieties and hydrophilic monomers, compositions, and applications thereof | ISP INVESTMENTS LLC (US) | 2025-12-16 | — | — | US | disclosed |
| US-20250032398-A1 | HIGH MOLECULAR WEIGHT BLOCK COPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES AND HYDROPHILIC MONOMERS, COMPOSITIONS, AND APPLICATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2025-01-30 | — | — | US | disclosed |
| WO-2025024325-A2 | ALL-ACRYLIC TRIBLOCK AND TETRABLOCK COPOLYMERS HAVING A LACTAM MOIETY AND APPLICATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2025-01-30 | — | — | WO | disclosed |
| US-11859029-B2 | Methods of synthesis of homopolymers and non-homopolymers comprising repeating units derived from monomers comprising lactam and acryloyl moieties in an aqueous medium | ISP INVESTMENTS LLC (US) | 2024-01-02 | — | — | US | disclosed |
| CN-109337097-B | Solvent and method for preparing cellulose solution by using same | 绍兴美标纺织品检验有限公司 | 2021-10-01 | — | — | CN | disclosed |
| US-10905636-B2 | Block copolymers comprising repeating units derived from monomers comprising lactam and acryloyl moieties and hydrophobic monomers, compositions, and applications thereof | ISP INVESTMENTS LLC (US) | 2021-02-02 | — | — | US | disclosed |
| US-20200407470-A1 | METHODS OF SYNTHESIS OF HOMOPOLYMERS AND NON-HOMOPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES IN AN AQUEOUS MEDIUM | ISP INVESTMENTS LLC (US) | 2020-12-31 | — | — | US | disclosed |
| US-10865440-B2 | Sample preparation, processing and analysis systems | IntegenX, Inc. (US) | 2020-12-15 | — | — | US | disclosed |
| US-20190382519-A1 | CROSS-LINKED BLOCK COPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES, COMPOSITIONS, AND APPLICATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2019-12-19 | — | — | US | disclosed |
| WO-2017123572-A1 | BLOCK COPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES AND HYDROPHOBIC MONOMERS, COMPOSITIONS, AND APPLICATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2017-07-20 | — | — | WO | disclosed |
| US-20150024436-A1 | SAMPLE PREPARATION, PROCESSING AND ANALYSIS SYSTEMS | INTEGENX INC, (US) | 2015-01-22 | — | — | US | disclosed |
| US-7803793-B2 | Heterocyclic derived metalloprotease inhibitors | JANSSEN PHARMACEUTICA NV (BE) | 2010-09-28 | — | — | US | disclosed |
| US-20080103129-A1 | HETEROCYCLIC DERIVED METALLOPROTEASE INHIBITORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-05-01 | — | — | US | disclosed |
| US-6924378-B2 | Method for production of aziridines and N-vinylamides | NIPPON SHOKUBAI CO., LTD. (JP) | 2005-08-02 | — | — | US | disclosed |
| US-20030204098-A1 | Method for production of aziridines and N-vinylamides | NIPPON SHOKUBAI CO., LTD. (JP) | 2003-10-30 | — | — | US | disclosed |
| US-5959001-A | LOW VISCOSITY; MIXTURE CONTAINING PIGMENT, PASTE-MAKING AGENT, AMINE OR SALT, ADDITION HOMO- OR COPOLYMER | BAYER AKTIENGESELLSCHAFT (DE) | 1999-09-28 | — | — | US | disclosed |
| EP-0808879-A2 | Pigment preparations | BAYER AG (DE) | 1997-11-26 | — | — | EP | disclosed |
| US-4331442-A | Process for dyeing cellulose textile materials by the padding process | BAYER AKTIENGESELLSCHAFT (DE) | 1982-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12497478-B2 | High molecular weight block copolymers comprising repeating units derived from monomers comprising lactam and acryloyl moieties and hydrophilic monomers, compositions, and applications thereof | MRPL9, PRMT9, MRPL19 | ENO1 4402/4885CYP3A4 4305/4885TSHR 1038/4885 |
| US-10905636-B2 | Block copolymers comprising repeating units derived from monomers comprising lactam and acryloyl moieties and hydrophobic monomers, compositions, and applications thereof | F9, ADCY9, MMS19 | ENO1 4335/4885CYP3A4 3430/4885TSHR 1628/4885 |
| US-20080103129-A1 | HETEROCYCLIC DERIVED METALLOPROTEASE INHIBITORS | ADAM17, MMP25, ADAM33 | ENO1 938/4885CYP3A4 761/4885TSHR 4534/4885 |
| US-20190382519-A1 | CROSS-LINKED BLOCK COPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES, COMPOSITIONS, AND APPLICATIONS THEREOF | ADSL, ABHD6, APH1B | ENO1 4474/4885CYP3A4 3142/4885TSHR 4275/4885 |
| US-20250032398-A1 | HIGH MOLECULAR WEIGHT BLOCK COPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES AND HYDROPHILIC MONOMERS, COMPOSITIONS, AND APPLICATIONS THEREOF | PCNA, ADSL, APH1B | ENO1 4381/4885CYP3A4 3590/4885TSHR 3587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.